Skip to content

Clinical trials

Completed Phase 2 Neurotoxicity Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20083
20091
20112
20121
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
City of Hope Medical Center1
Columbia University1
Fundacion Oncosur1
M.D. Anderson Cancer Center1
Marcela V. Maus, M.D.,Ph.D.1
Radiation Therapy Oncology Group1
Tri-Service General Hospital (TSGH)1
University College, London1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes12
Lymphoma3
Peripheral Nervous System Diseases3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial2
Lung Neoplasms2
Ovarian Neoplasms2
Burkitt Lymphoma1
Central Nervous System Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.